Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop

Molecular and Cellular Biology

Volumn 29, Issue 11, 2009, Pages 3076-3087

  Seo, Ji Heui ^a   Suenaga, Atsushi ^b   Hatakeyama, Mariko ^b   Taiji, Makoto ^b   Imamoto, Akira ^a,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b RIKEN   (Japan)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRK LIKE PROTEIN; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN CDC42; PROTEIN SH2; RAC PROTEIN; RAS PROTEIN; TYROSINE; CRK PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PEPTIDE; PHOSPHOTYROSINE; RAF PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; BINDING AFFINITY; CELL GROWTH; COMPUTER MODEL; CONTROLLED STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; BIOLOGY; CELL ADHESION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DRUG EFFECT; FEEDBACK SYSTEM; HUMAN; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN BINDING; SRC HOMOLOGY DOMAIN; STRUCTURE ACTIVITY RELATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; CELL ADHESION; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; FEEDBACK, BIOCHEMICAL; FIBROBLAST GROWTH FACTOR 8; HUMANS; MAP KINASE KINASE 1; MICE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MONOMERIC GTP-BINDING PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-CRK; RAF KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SRC HOMOLOGY DOMAINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 66349106792     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01686-08     Document Type: Article

References (45)

1. Alon, U. 2007. Network motifs: theory and experimental approaches. Nat. Rev. Genet. 8:450-461.
2. Anafi, M., M. K. Rosen, G. D. Gish, L. E. Kay, and T. Pawson. 1996. A potential SH3 domain-binding site in the Crk SH2 domain. J. Biol. Chem. 271:21365-21374.
3. Dell'Era, P., M. Mohammadi, and M. Presta. 1999. Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. Mol. Biol. Cell 10:23-33.
4. Donaldson, L. W., G. Gish, T. Pawson, L. E. Kay, and J. D. Forman-Kay. 2002. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide. Proc. Natl. Acad. Sci. USA 99:14053-14058.
5. Edin, M. L., and R. L. Juliano. 2005. Raf-1 serine 338 phosphorylation plays a key role in adhesion-dependent activation of extracellular signal-regulated kinase by epidermal growth factor. Mol. Cell. Biol. 25:4466-4475.
6. Feller, S. M. 2001. Crk family adaptors-signalling complex formation and biological roles. Oncogene 20:6348-6371. (Pubitemid 32977844)
7. Fletcher, R. B., J. C. Baker, and R. M. Harland. 2006. FGF8 spliceforms mediate early mesoderm and posterior neural tissue formation in Xenopus. Development 133:1703-1714. (Pubitemid 43810977)
8. Furdui, C. M., E. D. Lew, J. Schlessinger, and K. S. Anderson. 2006. Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. Mol. Cell 21:711-717. (Pubitemid 43290737)
9. Gilson, M. K., and H. X. Zhou. 2007. Calculation of protein-ligand binding affinities. Annu. Rev. Biophys. Biomol. Struct. 36:21-42.
10. Guo, Q., and J. Y. Li. 2007. Distinct functions of the major Fgf8 spliceform, Fgf8b, before and during mouse gastrulation. Development 134:2251-2260.
11. Guris, D. L., G. Duester, V. E. Papaioannou, and A. Imamoto. 2006. Dose-dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev. Cell 10:81-92. (Pubitemid 43025679)
12. Guris, D. L., J. Fantes, D. Tara, B. J. Druker, and A. Imamoto. 2001. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat. Genet. 27:293-298.
13. Harkiolaki, M., R. J. Gilbert, E. Y. Jones, and S. M. Feller. 2006. The C-terminal SH3 domain of CRKL as a dynamic dimerization module transiently exposing a nuclear export signal. Structure 14:1741-1753. (Pubitemid 44856779)
14. Hutson, M. R., P. Zhang, H. A. Stadt, A. K. Sato, Y. X. Li, J. Burch, T. L. Creazzo, and M. L. Kirby. 2006. Cardiac arterial pole alignment is sensitive to FGF8 signaling in the pharynx. Dev. Biol. 295:486-497.
15. King, A. J., H. Sun, B. Diaz, D. Barnard, W. Miao, S. Bagrodia, and M. S. Marshall. 1998. The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature 396:180-183. (Pubitemid 28523621)
16. Kobashigawa, Y., M. Sakai, M. Naito, M. Yokochi, H. Kumeta, Y. Makino, K. Ogura, S. Tanaka, and F. Inagaki. 2007. Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK. Nat. Struct. Mol. Biol. 14:503-510.
17. Kolch, W. 2005. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell. Biol. 6:827-837.
18. Ladbury, J. E., M. A. Lemmon, M. Zhou, J. Green, M. C. Botfield, and J. Schlessinger. 1995. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. Proc. Natl. Acad. Sci. USA 92:3199-3203.
19. Larsson, H., P. Klint, E. Landgren, and L. Claesson-Welsh. 1999. Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk. J. Biol. Chem. 274:25726-25734.
20. Li, L., D. L. Guris, M. Okura, and A. Imamoto. 2003. Translocation of CrkL to focal adhesions mediates integrin-induced migration downstream of Src family kinases. Mol. Cell. Biol. 23:2883-2892.
21. Meller, N., S. Merlot, and C. Guda. 2005. CZH proteins: a new family of Rho-GEFs. J. Cell Sci. 118:4937-4946. (Pubitemid 41672426)
22. Meyers, E. N., M. Lewandoski, and G. R. Martin. 1998. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18:136-141.
23. Mohammadi, M., I. Dikic, A. Sorokin, W. H. Burgess, M. Jaye, and J. Schlessinger. 1996. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16:977-989.
24. Mohammadi, M., J. Schlessinger, and S. R. Hubbard. 1996. Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86:577-587. (Pubitemid 26299489)
25. Moon, A. M., D. L. Guris, J. H. Seo, L. Li, J. Hammond, A. Talbot, and A. Imamoto. 2006. Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev. Cell 10:71-80. (Pubitemid 43025678)
26. Morris, M. C., J. Depollier, J. Mery, F. Heitz, and G. Divita. 2001. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19:1173-1176.
27. Olsen, S. K., J. Y. Li, C. Bromleigh, A. V. Eliseenkova, O. A. Ibrahimi, Z. Lao, F. Zhang, R. J. Linhardt, A. L. Joyner, and M. Mohammadi. 2006. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes Dev. 20:185-198. (Pubitemid 43112937)
28. Park, E. J., L. A. Ogden, A. Talbot, S. Evans, C. L. Cai, B. L. Black, D. U. Frank, and A. M. Moon. 2006. Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling. Development 133:2419-2433. (Pubitemid 44044562)
29. Park, E. J., Y. Watanabe, G. Smyth, S. Miyagawa-Tomita, E. Meyers, J. Klingensmith, T. Camenisch, M. Buckingham, and A. M. Moon. 2008. An FGF autocrine loop initiated in second heart field mesoderm regulates morphogenesis at the arterial pole of the heart. Development 135:3599-3610.
30. Park, T. J., K. Boyd, and T. Curran. 2006. Cardiovascular and craniofacial defects in Crk-null mice. Mol. Cell. Biol. 26:6272-6282.
31. Riley, B. M., M. A. Mansilla, J. Ma, S. Daack-Hirsch, B. S. Maher, L. M. Raffensperger, E. T. Russo, A. R. Vieira, C. Dode, M. Mohammadi, M. L. Marazita, and J. C. Murray. 2007. Impaired FGF signaling contributes to cleft lip and palate. Proc. Natl. Acad. Sci. USA 104:4512-4517.
32. Rosen, M. K., T. Yamazaki, G. D. Gish, C. M. Kay, T. Pawson, and L. E. Kay. 1995. Direct demonstration of an intramolecular SH2-phosphotyrosine interaction in the Crk protein. Nature 374:477-479.
33. Cas in fibroblasts. Oncogene 14:1419-1426.
34. Scholpp, S., C. Groth, C. Lohs, M. Lardelli, and M. Brand. 2004. Zebrafish fgfr1 is a member of the fgf8 synexpression group and is required for Fgf8 signalling at the midbrain-hindbrain boundary. Dev. Genes Evol. 214:285-295.
35. Shin, N. Y., R. S. Dise, J. Schneider-Mergener, M. D. Ritchie, D. M. Kilkenny, and S. K. Hanks. 2004. Subsets of the major tyrosine phosphorylation sites in Crk-associated substrate (CAS) are sufficient to promote cell migration. J. Biol. Chem. 279:38331-38337.
36. Slack-Davis, J. K., S. T. Eblen, M. Zecevic, S. A. Boerner, A. Tarcsafalvi, H. B. Diaz, M. S. Marshall, M. J. Weber, J. T. Parsons, and A. D. Catling. 2003. PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J. Cell Biol. 162:281-291. (Pubitemid 36928841)
37. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, et al. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778. (Pubitemid 23093884)
38. Suenaga, A., N. Takada, M. Hatakeyama, M. Ichikawa, X. Yu, K. Tomii, N. Okimoto, N. Futatsugi, T. Narumi, M. Shirouzu, S. Yokoyama, A. Konagaya, and M. Taiji. 2005. Novel mechanism of interaction of p85 subunit of phosphatidylinositol 3-kinase and ErbB3 receptor-derived phosphotyrosyl peptides. J. Biol. Chem. 280:1321-1326.
39. Taiji, M., T. Narumi, Y. Ohno, N. Futatsugi, A. Suenaga, N. Takada, and A. Konagaya. 2003. Protein Explorer: a Petaflops special-purpose computer system for molecular dynamics simulations, p. 15. In Proceedings of the 2003 ACM/IEEE Conference on Supercomputing. IEEE Computer Society, Washington, DC.
40. ten Hoeve, J., C. Morris, N. Heisterkamp, and J. Groffen. 1993. Isolation and chromosomal localization of CRKL, a human Crk-like gene. Oncogene 8:2469-2474.
41. Trokovic, N., R. Trokovic, P. Mai, and J. Partanen. 2003. Fgfr1 regulates patterning of the pharyngeal region. Genes Dev. 17:141-153. (Pubitemid 36062515)
42. Wang, J., Y. Deng, and B. Roux. 2006. Absolute binding free energy calculations using molecular dynamics simulations with restraining potentials. Biophys. J. 91:2798-2814. (Pubitemid 44526470)
43. Woo, H. J., and B. Roux. 2005. Calculation of absolute protein-ligand binding free energy from computer simulations. Proc. Natl. Acad. Sci. USA 102:6825-6830.
44. Yu, K., and D. M. Ornitz. 2008. FGF signaling regulates mesenchymal differentiation and skeletal patterning along the limb bud proximodistal axis. Development 135:483-491.
45. Zhang, X., O. A. Ibrahimi, S. K. Olsen, H. Umemori, M. Mohammadi, and D. M. Ornitz. 2006. Receptor specificity of the fibroblast growth factor family: the complete mammalian FGF family. J. Biol. Chem. 281:15694-15700.